Mari E. K. Niemi

Mari E. K. Niemi

Auto-generated profile, based on publicly available information

Mari E. K. Niemi

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2018 in Nature
Verified
Journal Article
Open access
PDF file
MNMari E. K. Niemi
Mari E. K. Niemi
HMHilary C. Martin
Hilary C. Martin
DRDaniel L. Rice
Daniel L. Rice
GGGiuseppe Gallone
Giuseppe Gallone
SGScott Gordon
Scott Gordon
JBJeffrey C. Barrett
Jeffrey C. Barrett
There are thousands of rare human disorders that are caused by single deleterious, protein-coding genetic variants1. However, patients with the same genetic defect can have different clinical presentations2,3,4, and some individuals who carry known disease-causing variants can appear unaffected5. Here, to understand what explains these differences, we study a cohort of 6,987 children assessed by clinical geneticists to have severe neurodevelopmental disorders such as global developmental delay and autism, often in combination with abnormalities of other organ systems. Although the genetic causes of these neurodevelopmental disorders are expected to be almost entirely monogenic, we show that 7.7% of variance in risk is attributable to inherited common genetic variation. We replicated this genome-wide common variant burden by showing, in an independent sample of 728 trios (comprising a child plus both parents) from the same cohort, that this burden is over-transmitted from parents to children with neurodevelopmental disorders. Our common-variant signal is significantly positively correlated with genetic predisposition to lower educational attainment, decreased intelligence and risk of schizophrenia. We found that common-variant risk was not significantly different between individuals with and without a known protein-coding diagnostic variant, which suggests that common-variant risk affects patients both with and without a monogenic diagnosis. In addition, previously published common-variant scores for autism, height, birth weight and intracranial volume were all correlated with these traits within our cohort, which suggests that phenotypic expression in individuals with monogenic disorders is affected by the same variants as in the general population. Our results demonstrate that common genetic variation affects both overall risk and clinical presentation in neurodevelopmental disorders that are typically considered to be monogenic.

7 December 2018 in Science
Verified
Journal Article
Closed access
PDF file
HMHilary C. Martin
Hilary C. Martin
WJWendy D. Jones
Wendy D. Jones
RMRebecca McIntyre
Rebecca McIntyre
GSGabriela Sanchez-Andrade
Gabriela Sanchez-Andrade
MSMark Sanderson
Mark Sanderson
OSon behalf of the Deciphering Developmental Disorders Study
on behalf of the Deciphering Developmental Disorders Study
Genetic architecture of developmental disorders: The genetics of developmental disorders (DDs) is complex. Martin et al. wanted to determine the degree of recessive inheritance of DDs in protein-coding genes. They examined the exomes of more than 6000 families in populations with high and low proportions of consanguineous marriages. They found that 3.6% of DDs in individuals of European ancestry involved recessive coding disorders, less than a tenth of the levels previously estimated. Furthermore, among South Asians with high parental relatedness, rather than most of the disorders arising from inherited variants, fewer than half had a recessive coding diagnosis. Science , this issue p. 1161

2 May 2022 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
MNMari E. K. Niemi
Mari E. K. Niemi
MDMark J. Daly
Mark J. Daly
AGAndrea Ganna
Andrea Ganna

1 December 2021 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
TNTomoko Nakanishi
Tomoko Nakanishi
SPSara Pigazzini
Sara Pigazzini
FDFrauke Degenhardt
Frauke Degenhardt
MCMattia Cordioli
Mattia Cordioli
GBGuillaume Butler-Laporte
Guillaume Butler-Laporte
AGAndrea Ganna
Andrea Ganna
Background. There is considerable variability in COVID-19 outcomes among younger adults, and some of this variation may be due to genetic predisposition. Methods. We combined individual level data from 13,888 COVID-19 patients (n = 7185 hospitalized) from 17 cohorts in 9 countries to assess the association of the major common COVID-19 genetic risk factor (chromosome 3 locus tagged by rs10490770) with mortality, COVID-19-related complications, and laboratory values. We next performed metaanalyses using FinnGen and the Columbia University COVID-19 Biobank. Results. We found that rs10490770 risk allele carriers experienced an increased risk of all-cause mortality (HR, 1.4; 95% CI, 1.2–1.7). Risk allele carriers had increased odds of several COVID-19 complications: severe respiratory failure (OR, 2.1; 95% CI, 1.6–2.6), venous thromboembolism (OR, 1.7; 95% CI, 1.2–2.4), and hepatic injury (OR, 1.5; 95% CI, 1.2–2.0). Risk allele carriers age 60 years and younger had higher odds of death or severe respiratory failure (OR, 2.7; 95% CI, 1.8–3.9) compared with those of more than 60 years (OR, 1.5; 95% CI, 1.2–1.8; interaction, P = 0.038). Among individuals 60 years and younger who died or experienced severe respiratory failure, 32.3% were risk-variant carriers compared with 13.9% of those not experiencing these outcomes. This risk variant improved the prediction of death or severe respiratory failure similarly to, or better than, most established clinical risk factors. Conclusions. The major common COVID-19 genetic risk factor is associated with increased risks of morbidity and mortality, which are more pronounced among individuals 60 years or younger. The effect was similar in magnitude and more common than most established clinical risk factors, suggesting potential implications for future clinical risk management.

23 March 2022 in Nature
Verified
Journal Article
Closed access
PDF file
EGEugene J. Gardner
Eugene J. Gardner
MNMatthew D. C. Neville
Matthew D. C. Neville
KSKaitlin E. Samocha
Kaitlin E. Samocha
KBKieron Barclay
Kieron Barclay
MKMartin Kolk
Martin Kolk
MHMatthew E. Hurles
Matthew E. Hurles

27 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
HMHilary C. Martin
Hilary C. Martin
EGEugene J. Gardner
Eugene J. Gardner
KSKaitlin E. Samocha
Kaitlin E. Samocha
JKJoanna Kaplanis
Joanna Kaplanis
NANadia Akawi
Nadia Akawi
MHMatthew E. Hurles
Matthew E. Hurles
Over 130 X-linked genes have been robustly associated with developmental disorders, and X-linked causes have been hypothesised to underlie the higher developmental disorder rates in males. Here, we evaluate the burden of X-linked coding variation in 11,044 developmental disorder patients, and find a similar rate of X-linked causes in males and females (6.0% and 6.9%, respectively), indicating that such variants do not account for the 1.4-fold male bias. We develop an improved strategy to detect X-linked developmental disorders and identify 23 significant genes, all of which were previously known, consistent with our inference that the vast majority of the X-linked burden is in known developmental disorder-associated genes. Importantly, we estimate that, in male probands, only 13% of inherited rare missense variants in known developmental disorder-associated genes are likely to be pathogenic. Our results demonstrate that statistical analysis of large datasets can refine our understanding of modes of inheritance for individual X-linked disorders.